HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial

HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial

© 2015 Elsevier Ltd. Background: Pre-exposure prophylaxis (PrEP) with oral emtricitabine and tenofovir disoproxil fumarate is used to prevent the sexual acquisition of HIV in groups at high risk such as transgender women. We used data from the iPrEx study to assess PrEP efficacy, effectiveness, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Madeline B. Deutsch, David V. Glidden, Jae Sevelius, Joanne Keatley, Vanessa McMahan, Juan Guanira, Esper G. Kallas, Suwat Chariyalertsak, Robert M. Grant, Javier Lama, Mauro Schechter, Valdilea Veloso, Linda Gail Bekker, Kenneth Mayer, Susan Buchbinder, Orlando Montoya, Martin Casapia, Sybil Hosek, Albert Liu, Rivet Amico, Kimberly Koester, Kathleen Mulligan
Format: Journal
Published: 2018
Subjects:
Immunology and Microbiology
Medicine
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959932232&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/54564
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959932232&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/54564

Similar Items